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Abstract 
Understanding the effects of muscle and fat on bone is increasingly important in the optimisation 
of bone health.  We explored relationships between bone microarchitecture and body 
composition in older men and women from the Hertfordshire Cohort Study.  175 men and 167 
women aged 72-81 years were studied. High resolution peripheral quantitative computed 
tomography (HRpQCT) images (voxel size 82μm) were acquired from the non-dominant distal 
radius and tibia with a Scanco XtremeCT scanner. Standard morphological analysis was 
performed for assessment of macrostructure, densitometry, cortical porosity and trabecular 
microarchitecture. Body composition was assessed using dual energy x-ray absorptiometry 
(DXA) (Lunar Prodigy Advanced). Lean mass index (LMI) was calculated as lean mass divided 
by height squared and fat mass index (FMI) as fat mass divided by height squared. The mean 
(standard deviation) age in men and women was 76 (3) years. In univariate analyses, tibial 
cortical area (p<0.01), cortical thickness (p<0.05) and trabecular number (p<0.01) were 
positively associated with LMI and FMI in both men and women. After mutual adjustment, 
relationships between cortical area and thickness were only maintained with LMI [tibial cortical 
area, β(95% confidence interval (CI)): men 6.99 (3.97,10.01), women 3.59 (1.81,5.38)] whereas 
trabecular number and density were associated with FMI.  Interactions by sex were found, 
including for the relationships of LMI with cortical area and FMI with trabecular area in both the 
radius and tibia (p<0.05).  In conclusion, LMI and FMI appeared to show independent 
relationships with bone microarchitecture.  Further studies are required to confirm the direction 
of causality and explore the mechanisms underlying these tissue-specific associations.    
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1. Introduction 
Sarcopenia is defined as the loss of skeletal muscle mass and strength that occurs with advancing 
age (1).  As current demographic shifts are leading to an ageing population, the number at risk of 
sarcopenia is growing.  Similarly, rates of obesity are also rising with dietary changes and more 
sedentary lifestyles.  Previous work has suggested that both sarcopenia and obesity relate to bone 
mineral density (BMD) and hence fracture risk (2-5).  Specifically, sarcopenia has been shown to 
be a risk factor for fracture through an increase in fall frequency (6, 7) and an association with 
poorer bone health (2, 3).    Obesity is associated with greater total body fat mass.  Interestingly, 
some studies have found areal BMD to be positively associated with fat mass (4, 5) whereas 
others did not (8, 9).   
 
The relationship between muscle and bone is driven by multiple mechanisms.  These include the 
hormones, such as growth hormone, with positive effects on both tissues and the mechanostat 
whereby forces from muscle contractions act to stimulate bone.  Dietary factors and physical 
activity are also thought to play a role.  Associations between fat and bone occur mainly through 
the action of oestrogen, which augments bone health, and adipokines, which can have both 
positive and negative effects.  Other hormones and cytokines have also been implicated.  
Furthermore, increased loading from greater adiposity may also influence bone through the 
mechanostat (10). 
 
Many epidemiological studies have assessed body composition using dual energy x-ray 
absorptiometry (DXA) (4, 8).  DXA provides estimates of lean mass and fat mass but does have 
limitations.  Although the majority of lean mass is made up of muscle, it also encompasses other 
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tissues including tendon and ligament.  Measurements can also be influenced by trunk thickness 
and level of tissue hydration, and ectopic fat is often significantly underestimated.  Using other 
imaging modalities, fat can additionally be subdivided by its distribution.  Studies have shown 
that subcutaneous adipose tissue (SAT) demonstrates different relationships with bone health 
than visceral adipose tissue (VAT) (11).   
 
Relationships with bone structure have also been explored.  Investigators have found consistent 
positive associations between lean mass and both bone geometry and estimates of bone strength 
(12-14).  Conversely, although some positive relationships have been shown between adiposity 
and bone geometry, the specific compartments affected have varied, and relationships with 
volumetric BMD, particularly cortical, have been inconsistent (12, 13, 15).  Furthermore, lean 
mass and fat mass are correlated; those with greater adiposity also tend to have larger muscles.  
Consequently, there is the potential for their relationships with bone health to confound one 
another.  Previous work, including from the Framingham study, has highlighted the importance 
of adjusting lean mass for total fat mass both in the assessment of sarcopenia prevalence and 
when assessing associations with adverse outcomes (16, 17). 
 
Although we are aware of some of the mechanisms through which muscle, fat and bone are 
interconnected, this area is not fully understood.  Further analysis is required to unpick the 
individual associations of muscle with bone and fat with bone.  These tissues are highly 
interdependent with mesenchymal stem cells having the capacity to differentiate into fat, bone or 
muscle. We know that fatty tissue may be deposited within muscle, particularly with advancing 
age, and this may also occur within bone (18).  It is very important to understand these 
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relationships as this may shed light on which mechanisms are most likely to be driving each of 
the independent associations identified.   
 
To date, the independent relationships of muscle and fat with bone microstructure, including 
trabecular microarchitecture and cortical porosity, have not been well described.  These bone 
parameters can now be assessed non-invasively, in vivo using high-resolution peripheral 
quantitative computed tomography (HRpQCT).  The purpose of the current study is to extend 
current knowledge by investigating the relationships of bone geometry, volumetric BMD, and 
bone microarchitecture with both lean mass and fat mass in a well phenotyped cohort of older 
men and women from Hertfordshire.    
 
2. Material and Methods 
2.1. Participants 
We recruited participants from the Hertfordshire Cohort Study (HCS) to perform an 
observational cross-sectional analysis. The HCS is a population-based cohort study in the United 
Kingdom (UK) designed to examine the relationships between growth in infancy and the 
subsequent risk of adult diseases, such as osteoporosis. Study design and recruitment have been 
described in detail previously (19). In brief, in conjunction with the National Health Service 
Central Registry and the Hertfordshire Family Health Service Association, we traced men and 
women who were born as singleton births between 1931 and 1939 in Hertfordshire and still lived 
there during the period 1998–2003.  In 2011-2012, 570 men and women from the geographical 
area of East Hertfordshire were invited for a follow up study and 376 (66%) agreed to 
participate.  Thirty four individuals were excluded due to the absence of full total body 
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composition results: 2 declined scanning; 1 was unable to tolerate the procedure; 8 had artefacts 
in both upper limbs and 23 had artefacts in both lower limbs preventing inclusion of that region 
(most commonly arthroplasties).  Whole body composition was therefore available in 342 (91%) 
participants who did not differ significantly from the overall recruited cohort (n=376) in terms of 
demographic and lifestyle factors (p>0.05 for age, sex, height, weight, calcium intake, vitamin D 
intake, physical activity, smoking status, alcohol consumption, and social class).    
 
2.2. Body composition  
Total lean mass (LM) (non-bone, non-fat mass) and fat mass (FM) were measured using dual-
energy X-ray absorptiometry (DXA) (Lunar Prodigy Advanced Scanner, GE Medical Systems, 
UK). Total tissue mass was defined as the sum of total lean mass and total fat mass.  Percentage 
lean mass was the proportion of total tissue mass made up by total lean mass.  Percentage fat 
mass was the proportion of total tissue mass made up by total fat mass.  In all cases, assessments 
were made excluding the head.  Positioning for all scans was completed in accordance with 
manufacturer instructions.  In vivo precision (root-mean square coefficient of variation (%CV)) 
for the DXA scanner has been determined for lean mass (1.87%) and fat mass (1.75%) by 
measuring 35 individuals twice on the same day with re-positioning.  
 
On average, taller individuals have greater lean mass and bone size.  Therefore, in definitions of 
sarcopenia, lean mass is often assessed as lean mass index (LMI) by dividing by height squared 
(20-22).  The function of dividing by height squared has been shown to minimise the correlation 
between lean mass and height (21).  Fat mass index (FMI) has also been developed akin to body 
mass index (BMI) (23).  LMI and FMI were calculated in this way in the current study. 
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2.3. HRpQCT 
Each participant had measurements of the non-dominant distal radius and tibia using HRpQCT 
(XtremeCT, Scanco Medical AG, Switzerland) except when the non-dominant limb had 
previously fractured in which case the dominant side was scanned.  This allowed acquisition of a 
stack of parallel CT slices using a two-dimensional detector array.  At both sites a total of 110 
slices were obtained which represented a volume of bone 9mm in axial length with a nominal 
resolution (voxel size) of 82μm.  The scanned limb was immobilized during the examination in a 
carbon fibre cast.  Antero-posterior 2D scout views were performed to determine the region to be 
scanned.  Positioning was in keeping with the manufacturer’s guidelines and as described by 
Boutroy et al (24). All scans were acquired by one of two trained technicians using standard 
positioning techniques.  Each scan was assessed for motion artefact, and if present a second scan 
was performed.  A total of 7 radial images and 3 tibial images were excluded due to excessive 
motion artefact (25).  Initial image analysis was carried out using the standard manufacturer’s 
method and Image Processing Language (IPL, Version 6.1, ScancoMedical).  Further analysis 
was performed using an automated segmentation algorithm (26).  Each measure used has been 
validated against micro-CT imaging (27). 
 
Quality control testing was performed on a weekly basis and quality assurance on a daily basis.  
Short term precision values (%CV) for cortical and trabecular BMD have been shown to range 
from 0.3 to 1.2 (28).  The effective dose to the subject during each scan was <3μSv.   
 
2.4. Anthropometry and Interviews 
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Height was measured to the nearest 0.1 cm using a wall-mounted SECA stadiometer on the day 
of scanning.  Details regarding physical activity, dietary calcium intake, smoking status, alcohol 
consumption, socioeconomic status and, in women, years since menopause and use of estrogen 
replacement therapy were collected from researcher-administered questionnaires.  Physical 
activity was calculated as a standardised score ranging from 0–100 derived from frequency of 
gardening, housework, climbing stairs and carrying loads in a typical week based on the 
questionnaire of customary physical activity by Dallosso et al. (29). Higher scores indicated 
greater levels of activity.  Dietary calcium intake and vitamin D intake (excluding supplements) 
were assessed using a food frequency questionnaire (30).  Socioeconomic status was determined 
using current or most recent occupation of the participant in men and single women, and of the 
husband in ever-married women based on the Office of Population Censuses and Surveys 
Standard Occupational Classification Scheme for occupation and social class. 
 
The East and North Hertfordshire Ethical Committees granted ethical approval for the study and 
all participants gave written informed consent in accordance with Governance Arrangements for 
NHS Research Ethics Committees Harmonised edition (September 2011) (31). 
 
2.5. Statistical analysis 
Due to differences in bone and body composition variables between men and women, and 
significant sex-interactions for relationships between body composition and HRpQCT 
parameters in the study cohort, we presented results separately for the two sexes. Study 
participant demographic and lifestyle characteristics, and body composition and HRpQCT 
measures were therefore described separately for men and women.  Continuous variables were 
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described as means [standard deviations (SDs)] and categorical and binary variables were 
summarised by counts and percentages.  Differences between demographic and lifestyle 
characteristics in men and women were assessed using Student’s t-tests for continuous variables 
and Pearson’s Χ2 test or Fisher’s exact test for categorical variables.  Multiple testing was then 
taken into consideration using a Bonferroni correction. 
 
The primary analysis used multivariable linear regression to examine the associations between 
the measures of body composition (LMI and FMI) and HRpQCT bone parameters in the radius 
and tibia while examining sex interactions.  To probe the significant interactions, the same 
relationships were then examined for men and women separately. To provide a graphical 
representation comparing regression coefficients across different bone parameters, anatomical regions of 
interests and between the sexes, relationships were reanalysed after standardization and differences 
were expressed as SD change in outcome per SD increase in predictor.  These analyses were 
repeated with and without adjustment for a priori confounders: age, smoking status, alcohol 
consumption, calcium intake, vitamin D intake, physical activity, social class, and in women, 
years since menopause and estrogen replacement therapy.  
 
Bone microarchitectural parameters were then regressed on both LMI and FMI within the same 
model.  Due to the potential correlation between LMI and FMI, regression analysis of FMI 
against LMI was carried out to produce standardised FMI residuals – the difference between the 
observed FMI and the value that would be estimated purely as a function of LMI.  The process of 
regression analysis was repeated to produce LMI residuals.  HRpQCT outcomes were then 
regressed on LMI and FMI residuals, and vice versa.  These analyses were repeated with and 
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without adjustment for a priori confounders as described above.  Furthermore, as both LMI and 
FMI include height a further model using lean mass, fat mass and height was also produced to 
ensure over-adjustment for height had not occurred.  Statistical significance was assessed at the 
alpha = 0.05 level.  Data were analysed using STATA version 12. 
 
3. Results 
The mean (SD) age of participants was 76 (3) years.  On average, men were taller and heavier 
than women but BMI did not differ significantly by sex (table 1).  59.5% of men were current or 
ex-smokers whereas this figure was just 34.0% in women.  Social class was similar in men and 
women.  Table 2 describes components of body composition and bone microarchitecture in men 
and women. 
 
With the exception of radial cortical thickness in women, positive relationships were found 
between both LMI and FMI with cortical area and thickness in both the radius and tibia (figure 
1).  Associations were stronger in the tibia than the radius and standardised regression 
coefficients tended to be greater for LMI than FMI.  Radial and tibial trabecular number was 
positively associated with both LMI and FMI.  FMI also showed a positive relationship with 
trabecular density.  Adjustment for demographic and lifestyle covariates (age, smoking status, 
alcohol consumption, calcium intake, vitamin D intake, physical activity, social class, and in 
women, years since menopause and estrogen replacement therapy) did not materially affect the 
relationships described (table 3).  Interactions by sex were found for the relationships of LMI 
with radial cortical area and tibial cortical area and thickness, and for the relationships of FMI 
with radial total area, radial trabecular area and tibial trabecular area. 
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When HRpQCT outcomes were regressed on LMI and FMI within the same model and again 
adjusted for demographic and lifestyle covariates, LMI was positively associated with cortical 
area and thickness in both men and women although this did not reach statistical significance for 
radial cortical thickness in women.  Conversely, FMI was positively associated with trabecular 
number and inversely related to trabecular separation, although associations with trabecular 
separation did not reach statistical significance in the radius (table 4).  These findings are similar 
to associations between bone microarchitecture and LMI residuals and FMI residuals 
respectively, and to the associations of bone microarchitecture with lean mass and fat mass when 
included in the same model and adjusted for height (results not shown).  
 
4. Discussion 
LMI and FMI showed differing relationships with bone microarchitecture as assessed by 
HRpQCT at the distal radius and tibia.  After LMI and FMI were mutually adjusted for one 
another, relationships with trabecular number were maintained for FMI whereas LMI was only 
found to be associated with cortical area and thickness.  Sex interactions were found for the 
relationships between LMI and cortical area, and between FMI and trabecular area in both the 
radius and tibia.   
 
In univariate analyses LMI and FMI were positively associated with cortical area, cortical 
thickness, and trabecular number.  Mutual adjustment of LMI for FMI and vice versa, led to 
attenuation of relationships between FMI and cortical geometry whereas relationships with LMI 
remained robust.  A similar pattern was shown for LMI residuals when included in a model with 
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FMI. The relationship between LMI and cortical geometry is in keeping with the wider literature 
using pQCT which has shown analogous relationships between estimations of muscle mass and 
cortical geometry in 48 middle-aged (mean age 49.4±2.4 years) adults (32) and cohorts of older 
men and women (59.4±7.2 years (33) and >60 years (2)).   
 
The independent relationship between lean mass and cortical geometry can be explained in 
several ways.  The mechanostat hypothesis states that muscles apply forces to bones during 
contractions that cause deformations, or strains, within the bone tissue (10).  These are sensed, 
predominantly by osteocytes, and provide stimuli for the bone to increase or maintain its 
strength; one such way it might do this is through an increase in cortical area and thickness.  
Clearly, the mechanostat may not be the sole mechanism of association as muscle size has been 
shown to be more strongly related to bone structure than muscle strength in older men and 
women (2) although this may partly be due to grip strength not accurately measuring the forces 
applied to bone by muscle contractions.  Interestingly, an interaction by sex was identified for 
the relationship between LMI and cortical area in both the radius and tibia.  In men, there was a 
significantly greater positive association.  One possible explanation for this might be that muscle 
produces higher forces in men than women.  Consequently, any increase in muscle size is likely 
to have a greater absolute change in the force applied to bone leading to a greater effect on bone 
structure. 
 
Another reason why lean mass might correlate with bone health would include a common 
developmental component.  In keeping with the developmental origins hypothesis, there is 
evidence that both muscle and bone strength are associated with early life environment (34, 35).  
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Shared genetic and hormonal factors may also play a role.  Both may positively impact muscle 
and bone growth, either directly or indirectly, resulting in a positive correlation between these 
two facets of musculoskeletal health (36).  Lastly, exercise can affect both bone structure and 
muscle size in later life (37, 38).  Although we attempted to adjust for the effect of 
contemporaneous physical activity, we were not able to account for exercise levels in childhood 
and early adulthood which may have had significant and enduring effects on lean mass and bone 
health.  
 
In univariate analyses, both FMI and LMI were positively associated with trabecular number.  
The magnitude of this association was greater for FMI and this parameter was also positively 
related to trabecular density.  Relationships between fat mass and trabecular density have been 
inconsistent in previous studies.  In 140 postmenopausal women (mean age 68.4 years), assessed 
by Ng and colleagues using HRpQCT, a positive association was found between total body fat 
and radial trabecular density but, as in our study, it failed to reach statistical significance at this 
site in 169 older men (mean age 68.7 years).  Positive relationships were also shown between fat 
mass and trabecular number in both men and women (11).   
 
However, in a study of 50 slightly younger obese men and women with metabolic syndrome 
(mean age 34.6 years) significant associations between fat mass and bone microarchitecture were 
not found (39).  This deviance from the results of the current study may be due to the younger 
age of the participants or related to the lack of underweight, normal and overweight individuals 
within the cohort. 
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In contrast to cortical parameters, in the current study relationships with trabecular number were 
fully attenuated for LMI after adjustment for FMI and an independent association with bone 
microarchitecture was only present for FMI.  If the relationship between body composition and 
trabecular number was purely a weight-bearing effect then we would have expected a similar 
association with LMI.  Therefore, this suggests that the univariate association between LMI and 
trabecular number occurs through confounding by FMI and the relationship between FMI and 
trabecular number is not purely a weight-bearing effect, instead inferring the importance of 
independent biological mechanisms relating to adipose tissue, which will now be discussed.  
 
An epidemiological study exploring data from twins and their first degree relatives has shown 
that fat mass and BMD in both the hip and lumbar spine and likely to be influenced by common 
genes, suggesting these genes may have pleotrophic effects related to both adiposity and bone 
health (4).  There is evidence of a link between poorer trabecular bone health and greater marrow 
adiposity (40) which may be found in individuals with greater FMI (41).  Several endocrine 
factors can also influence the fat-bone relationship.  In particular, adipokines, such as leptin and 
adiponectin, are thought to play an important role (42, 43).  Leptin is produced by adipocytes and 
its level is proportional to total body fat mass; it is therefore elevated in obesity (44).  Osteoblasts 
and chondrocytes have leptin receptors and leptin may increase osteoblast differentiation and 
proliferation, and through the RANKL-OPG axis, inhibit osteoclastogenesis (42, 45). In this way 
leptin may increase skeletal mass to support the greater fat mass.  Adiponectin’s mechanism of 
action is not fully understood but is likely to relate to direct effects on osteoblasts and osteoclasts 
(46).  Although, like leptin, it is produced in fat cells, levels are inversely related to BMI (47).  
Adiponectin levels are negatively associated with BMD (43) and therefore as individuals with 
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higher FMI would have lower levels of adiponectin they would be expected to have a higher 
BMD.   
 
Adipocytes also produce estrogen, under the regulation of several paracrine and autocrine factors 
(48), and in postmenopausal women this is the main source.  FM has also been shown to increase 
the levels of bioavailable estradiol by directly inhibiting production of sex hormone binding 
globulin in the liver (49).  Estrogen is well established to have beneficial effects on bone and 
may therefore play a role in the relationship found.  It can also have positive effects on muscle 
function, for example through improved repair and regeneration (50).  This may further augment the 
univariate relationship between fat and bone. 
 
Insulin also influences bone health.  It is co-secreted with amylin and preptin and these hormones 
are found at higher levels in obesity.  Insulin, amylin and preptin have all been shown to 
stimulate osteoblast growth.  Amylin additionally inhibits osteoclastic function and thus bone 
resorption.  Epidemiological studies are consistent with these effects showing hypoinsulinaemia 
to be associated with low BMD (51).    
 
The cohort in which this study was completed is unique and important to discuss.  It comprises a 
group of men and women born as singleton births between 1931 and 1939 that were traced 
through their birth records.  Its main strengths are that it is well phenotyped which allows 
adjustment for potential covariates.  It is also community based, includes both men and women, 
and has been shown to be fairly representative of the UK population by means of a comparison 
with the Health Survey for England (19).  The results are therefore likely to be generalizable to 
this population.  However, those studied were entirely Caucasian and recruited one specific 
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region of Hertfordshire.  Thus, extrapolation of the findings to other ethnic groups and regions is 
uncertain.  Furthermore, body composition data was only available on a subset (91%) of 
participants and therefore current analyses were limited to this group.  Although it is possible 
that this might affect external validity, this group was not found to differ significantly from the 
overall study cohort.  The cohort also has a narrow age range and associations may vary across 
different stages of adulthood, particularly in women.  Consequently, the study is likely to provide 
useful information about older individuals but this may not be as applicable to other 
demographic groups.  Other limitations of the study include its cross-sectional design which 
makes attribution of causality difficult.  Furthermore, bone microarchitecture was studied in the 
extremities whereas components of body composition were assessed within the whole body 
minus head.  This clearly limits evaluation of direct local associations. 
 
5. Conclusions 
We have demonstrated that LMI was positively associated with radial and tibial cortical 
geometry independent of FMI.  Whereas, FMI was positively associated with trabecular number 
independent of LMI.  Furthermore, interactions by sex were also found, including for the 
relationships of LMI with cortical area and FMI with trabecular area in both the radius and tibia.  
To our knowledge, this study is the first to demonstrate these findings.  Components of body 
composition therefore clearly display important relationships with bone structure.  However, 
longitudinal analyses are required to confirm the direction of causality.   The differing 
associations identified may reflect predominantly physical elements relating muscle to cortical 
bone, and endocrine factors from adipose tissue affecting trabecular bone with its greater rate of 
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turnover.  However, an understanding of the precise mechanisms involved will require further 
investigation.   
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Table 1: Summary of participant characteristics 
 
Variable 
Women 
Total N            Mean (SD)     
Men 
Total N          Mean (SD) 
p value
e 
Age
a 
 
167 76.4 (2.6) 175 76.0 (2.6) 0.135 
Height (cm) 
 
167 160.2 (6.3) 175 173.6 (6.5) <0.001 
Weight (kg) 
 
167 71.1 (12.6) 175 81.8 (11.7) <0.001 
BMI (kg/cm
2
) 
 
167 27.7 (4.7) 175 27.2 (3.7) 0.227 
Weekly calcium 
intake (mg)
 
167 7906 (2685) 175 8503 (2039) 0.021 
      
Vitamin D intake 
(ug) 
167 25.7 (10.3) 175 25.8 (11.4) 0.902 
      
Physical activity 
score 
167 61.9 (13.2) 175 66.0 (13.1) 0.005 
      
 Total N n (%) Total N n (%)  
Smoker status 
   Never 
   Ex 
   Current 
165  
109 (66.1) 
48 (29.1) 
8 (4.8) 
175  
71 (40.6) 
92 (52.6) 
12 (6.9) <0.001 
      
Alcohol intake 
  None 
  ≤Recommendb 
  >Recommend 
166  
33 (19.9) 
130 (78.3) 
3 (1.8) 
175  
9 (5.1) 
136 (77.7) 
30 (17.1) <0.001 
      
Social status
c 
   I-IIINM 
   IIIM-V 
167  
72 (43.1) 
95 (56.9) 
169  
77 (45.6) 
92 (54.4) 0.651 
      
Years since 
menopause
d 
   <5 yrs 
   5 to <10 yrs 
   10 to <15 yrs 
   15 to <20 yrs 
    >20 yrs 
    Hysterectomy 
164  
 
4 (2.4) 
18 (11.0) 
37 (22.6) 
32 (19.5) 
30 (18.3) 
43 (26.2) 
NA NA 
NA 
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HRT (ever use)
d
 
    Yes 
    No 
167  
69 (41.3) 
98 (58.7) 
NA NA 
NA 
a 
At time of scans; 
b 
Recommended maximum weekly consumption of alcohol (14 units for 
women, 21 units for men); 
c 
I-IIINM (I to III non-manual), IIIM-V (III manual to V); 
d
 Years 
since menopause and Hormone Replacement Therapy as measured at HCS baseline (1998-2003); 
e 
Bonferroni correction used to adjust significance level to p<0.005 
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Table 2 – Summary of body composition by dual energy X-ray absoptiometry and bone 
microarchitecture by high resolution peripheral quantitative computed tomography in men and 
women.  
 
Variable 
 Women 
Mean (SD) 
 
Men 
Mean (SD) 
Whole body DXA
1    
Tissue Mass (kg)  68.24 (12.24) 78.84 (11.55) 
Fat Mass (kg)  29.63 (9.28) 25.12 (8.35) 
Fat Mass Index (kg/m
2
)  11.55 (3.59) 8.35 (2.76) 
Fat Mass (% of tissue)  42.48 (6.79) 31.18 (6.78) 
Lean Mass (kg)  38.62 (4.41) 53.72 (5.27) 
Lean Mass Index (kg/m
2
)  15.06 (1.55) 17.82 (1.44) 
Lean Mass (% of tissue)  57.51 (6.79) 68.83 (6.78) 
    
    
HRpQCT
2    
Total area (mm
2
) R 286.2 (42.8) 427.0 (78.5) 
 T 716.0 (101.5) 904.1 (145.3) 
Cortical area (mm
2
) R 47.2 (8.5) 72.0 (14.2) 
 T 93.1 (16.3) 142.2 (27.3) 
Cortical thickness (microm) R 682.0(165.1) 838.2(195.6) 
 T 917.3(192.2) 1224.2(260.9) 
Cortical density (mg/cm
3
) R 902.7 (59.4) 908.2 (48.9) 
 T 810.1 (64.9) 874.3 (59.8) 
Cortical porosity (%) R 3.6 (1.4) 4.1 (1.5) 
 T 10.0 (2.6) 8.9 (2.5) 
Trabecular area (mm
2
) R 237.3 (44.3) 350.4 (74.8) 
 T 621.8 (108.0) 761.5 (149.5) 
Trabecular density (mg/cm
3
) R 142.0 (43.1) 178.9 (37.1) 
 T 170.2 (40.7) 188.2 (34.9) 
Trabcular number(cm
-1
) R 20.6(4.1) 23.4(2.5) 
 T 22.6(3.6) 24.3(3.0) 
Trabecular thickness (microm) R 56.7(10.6) 63.5(10.3) 
 T 62.8(12.0) 64.8(9.8) 
Trabecular separation (microm) R 454.9(145.4) 370.2(62.6) 
 T 392.8(88.1) 354.0(54.3) 
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1
n=167 for women and 175 for men.  
2
In the radius, n=164 for women and 171 for men; in the 
tibia, n=164 for women and 175 for men.  R, radius; T, tibia.
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Table 3 – Lean mass index and fat mass index individually regressed on HRpQCT outcomes by sex with adjustment for covariates*.  
  
Lean mass index 
 
Fat mass index 
  
Men Women 
 
Men Women 
  
Beta (95% CI) p-value Beta (95% CI) p-value 
 
Beta (95% CI) p-value Beta (95% CI) p-value 
Total area 
(mm
2
) 
R 4.02 (-5.11,13.15) 0.386 4.63 (-0.05,9.32) 0.053 
 
-4.47 (-9.32,0.38) 0.071
†
 1.41 (-0.61,3.42) 0.171
†
 
T 6.38 (-10.08,22.83) 0.445 4.41 (-6.15,14.96) 0.411 
 
-5.26 (-14.01,3.49) 0.237 2.19 (-2.38,6.76) 0.344 
Cortical area 
(mm
2
) 
R 2.90 (1.35,4.44) <0.001
†
 1.38 (0.48,2.28) 0.003
†
 
 
0.72 (-0.13,1.57) 0.098 0.48 (0.09,0.86) 0.017 
T 7.91 (5.10,10.72) <0.001
†
 4.49 (2.93,6.05) <0.001
†
 
 
2.70 (1.12,4.29) 0.001 1.56 (0.85,2.26) <0.001 
Cortical 
thickness (µm) 
R 33.47 (11.70,55.24) 0.003 9.28 (-8.75,27.32) 0.311 
 
12.48 (0.67,24.29) 0.038 3.40 (-4.33,11.13) 0.386 
T 60.34 (32.78,87.90) <0.001
†
 33.16 (13.74,52.58) 0.001
†
 
 
22.40 (7.24,37.57) 0.004 9.50 (0.90,18.10) 0.031 
Cortical density 
(mg/cm
3
) 
R 2.58 (-2.91,8.06) 0.355 -3.21 (-9.63,3.22) 0.325 
 
-0.73 (-3.71,2.25) 0.630 -0.52 (-3.28,2.23) 0.707 
T 4.41 (-2.27,11.09) 0.194 6.52 (-0.32,13.36) 0.061 
 
0.63 (-2.96,4.22) 0.731 3.43 (0.49,6.38) 0.023 
Cortical porosity 
(%) 
R 0.06 (-0.09,0.22) 0.419 0.06 (-0.09,0.22) 0.414 
 
0.07 (-0.01,0.15) 0.097 0.00 (-0.06,0.07) 0.956 
T 0.08 (-0.19,0.36) 0.559 0.03 (-0.26,0.32) 0.832 
 
0.11 (-0.04,0.25) 0.158 0.02 (-0.11,0.14) 0.788 
Trabecular area 
(mm
2
) 
R 1.78 (-6.93,10.50) 0.686 3.50 (-1.35,8.35) 0.156 
 
-4.17 (-8.79,0.45) 0.076
†
 1.11 (-0.97,3.19) 0.294
†
 
T -2.38 (-19.24,14.49) 0.781 0.39 (-10.80,11.57) 0.946 
 
-8.72 (-17.63,0.18) 0.055
†
 0.88 (-3.97,5.72) 0.721
†
 
Trabecular 
density 
(mg/cm
3
) 
R 1.98 (-2.21,6.17) 0.352 3.16 (-1.34,7.67) 0.167 
 
1.79 (-0.44,4.02) 0.115 2.18 (0.27,4.09) 0.025 
T 1.97 (-1.93,5.88) 0.320 1.44 (-2.80,5.69) 0.503 
 
2.50 (0.45,4.55) 0.017 1.50 (-0.32,3.33) 0.105 
Trabecular 
number (cm
-1
) 
R 0.23 (-0.05,0.51) 0.108 0.40 (-0.03,0.83) 0.070 
 
0.19 (0.04,0.33) 0.014 0.29 (0.11,0.47) 0.002 
T 0.54 (0.23,0.86) 0.001 0.59 (0.22,0.96) 0.002 
 
0.44 (0.28,0.60) <0.001 0.34 (0.18,0.49) <0.001 
Trabecular 
thickness (µm) 
R 0.06 (-1.10,1.21) 0.925 0.01 (-1.13,1.14) 0.992 
 
0.13 (-0.49,0.75) 0.684 -0.00 (-0.49,0.48) 0.993 
T -0.78 (-1.87,0.30) 0.154 -0.96 (-2.24,0.32) 0.141 
 
-0.27 (-0.85,0.31) 0.362 -0.38 (-0.94,0.17) 0.177 
Trabecular 
separation (µm) 
R -5.59 (-12.74,1.56) 0.124 -9.08 (-24.50,6.34) 0.246 
 
-3.45 (-7.27,0.37) 0.076 -7.43 (-13.95,-0.92) 0.026 
T -7.75 (-13.62,-1.89) 0.010 -12.05 (-21.25,-2.85) 0.011 
 
-6.79 (-9.81,-3.77) <0.001 -6.43 (-10.37,-2.49) 0.002 
 
Key: In bold if p<0.05.  R, radius; T, tibia.  *Covariates are age at HRpQCT scan, smoking status, alcohol consumption, calcium 
intake, vitamin D intake, physical activity and social class; with additional adjustment for years since menopause and HRT use in 
women.  
†
Significant sex interaction (p<0.05).  
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Table 4 – Lean mass index and fat mass index within mutually adjusted model, regressed on HRpQCT outcomes by sex with 
adjustment for covariates*. 
  
Lean mass index 
 
Fat mass index 
  
Men Women 
 
Men Women 
  
Beta (95% CI) p-value Beta (95% CI) p-value 
 
Beta (95% CI) p-value Beta (95% CI) p-value 
Total area 
(mm
2
) 
R 8.45 (-1.29,18.19) 0.089 3.99 (-1.45,9.43) 0.149 
 
-6.20 (-11.42,-0.98) 0.020 0.54 (-1.79,2.87) 0.645 
T 12.10 (-5.55,29.75) 0.178 2.50 (-9.72,14.71) 0.687 
 
-7.70 (-17.12,1.73) 0.109 1.65 (-3.64,6.94) 0.538 
Cortical area 
(mm
2
) 
R 2.77 (1.10,4.44) 0.001 1.10 (0.06,2.14) 0.038 
 
0.15 (-0.74,1.05) 0.741 0.24 (-0.21,0.68) 0.291 
T 6.99 (3.97,10.01) <0.001 3.59 (1.81,5.38) <0.001 
 
1.30 (-0.31,2.91) 0.114 0.78 (0.01,1.55) 0.048 
Cortical 
thickness (µm) 
R 27.92 (4.39,51.45) 0.020 7.08 (-13.87,28.02) 0.505 
 
6.75 (-5.85,19.36) 0.292 1.87 (-7.10,10.84) 0.680 
T 51.30 (21.61,80.99) 0.001 29.59 (7.12,52.06) 0.010 
 
12.08 (-3.77,27.93) 0.134 3.09 (-6.64,12.83) 0.531 
Cortical density 
(mg/cm
3
) 
R 3.32 (-2.70,9.34) 0.278 -3.47 (-10.94,3.99) 0.360 
 
-1.41 (-4.63,1.82) 0.390 0.22 (-2.97,3.42) 0.890 
T 4.50 (-2.75,11.75) 0.222 3.41 (-4.45,11.27) 0.392 
 
-0.28 (-4.15,3.59) 0.887 2.70 (-0.71,6.10) 0.120 
Cortical porosity 
(%) 
R 0.02 (-0.15,0.19) 0.798 0.08 (-0.10,0.26) 0.362 
 
0.07 (-0.02,0.16) 0.152 -0.02 (-0.09,0.06) 0.680 
T 0.01 (-0.29,0.31) 0.940 0.02 (-0.32,0.35) 0.929 
 
0.10 (-0.06,0.26) 0.202 0.01 (-0.13,0.16) 0.851 
Trabecular area 
(mm
2
) 
R 5.86 (-3.46,15.17) 0.216 2.95 (-2.69,8.58) 0.303 
 
-5.37 (-10.37,-0.38) 0.035 0.47 (-1.94,2.89) 0.699 
T 4.85 (-13.21,22.90) 0.597 -0.84 (-13.79,12.12) 0.899 
 
-9.70 (-19.34,-0.06) 0.049 1.06 (-4.55,6.67) 0.710 
Trabecular 
density 
(mg/cm
3
) 
R 0.77 (-3.75,5.30) 0.736 0.80 (-4.38,5.97) 0.762 
 
1.63 (-0.79,4.06) 0.186 2.01 (-0.21,4.23) 0.075 
T 0.22 (-3.94,4.38) 0.917 -0.39 (-5.28,4.49) 0.874 
 
2.46 (0.23,4.68) 0.030 1.59 (-0.52,3.70) 0.139 
Trabecular 
number (cm
-1
) 
R 0.12 (-0.18,0.42) 0.437 0.08 (-0.42,0.57) 0.760 
 
0.16 (0.00,0.32) 0.048 0.27 (0.06,0.49) 0.011 
T 0.28 (-0.04,0.60) 0.089 0.27 (-0.15,0.68) 0.208 
 
0.38 (0.21,0.56) <0.001 0.28 (0.10,0.46) 0.002 
Trabecular 
thickness (µm) 
R -0.08 (-1.34,1.18) 0.905 0.01 (-1.31,1.33) 0.986 
 
0.14 (-0.53,0.82) 0.674 -0.00 (-0.57,0.56) 0.987 
T -0.71 (-1.88,0.46) 0.232 -0.69 (-2.17,0.79) 0.357 
 
-0.13 (-0.75,0.50) 0.693 -0.23 (-0.87,0.41) 0.477 
Trabecular 
separation (µm) 
R -3.76 (-11.48,3.97) 0.338 -0.43 (-18.13,17.26) 0.961 
 
-2.68 (-6.81,1.46) 0.203 -7.34 (-14.92,0.24) 0.057 
T -3.51 (-9.61,2.59) 0.258 -6.17 (-16.66,4.31) 0.246 
 
-6.09 (-9.34,-2.83) <0.001 -5.09 (-9.63,-0.55) 0.028 
 
Key: In bold if p<0.05.  R, radius; T, tibia.  *Covariates are age at HRpQCT scan, smoking status, alcohol consumption, calcium 
intake, vitamin D intake, physical activity and social class; with additional adjustment for years since menopause and HRT use in 
women  
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Figure 1 – Regression coefficients and 95% confidence intervals for HRpQCT parameters by lean mass index (black boxes) and fat 
mass index (white boxes); all variables expressed as z-scores
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Highlights 
• Lean mass index is independently associated with cortical geometry. 
• Fat mass index is related to trabecular microarchitecture after adjustment for lean mass 
index. 
• Further studies are required to confirm the direction of causality and explore the 
mechanisms underlying these tissue-specific associations.  
